senicapoc (ICA-17043)

From Aaushi
Jump to navigation Jump to search

Indications

Mechanism of action

More general terms

References

  1. Ataga KI, Smith WR, De Castro LM, Swerdlow P et al Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia. Blood. 2008 Apr 15;111(8):3991-7. Epub 2008 Jan 11. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18192510
  2. Joiner CH. Gardos pathway to sickle cell therapies? Blood. 2008 Apr 15;111(8):3918-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18434967

Database